Effects of GLP-1RAs on cardiovascular outcomes in patients with type 2 diabetes mellitus: review of real-world data on target populations from diabetes registry in Russian Federation [PDF]
, 2022 RATIONALE. Over the past 20 years the prevalence of type 2 diabetes in Russia has more than doubled and reached 4.43 million people in 2020, while the growth rate keeps increasing.
G. R. Galstyan +2 more
core +1 more source
Management of diabetes during Ramadan: an update for Russian-speaking doctors [PDF]
, 2023 Fasting during the Islamic Ramadan month is one of the five obligatory pillars for each adult, healthy, and sane Muslim. People with severe illnesses, including type 1 and type 2 diabetes mellitus are exempt from fasting.
A. I. Burotina +8 more
core +1 more source
Standards of specialized diabetes care. Edited by Dedov I.I., Shestakova M.V., Mayorov A.Yu. 10th edition [PDF]
, 2022 Dear Colleagues!We are glad to present the 10th Edition (revised) of the Standards of Specialized Diabetes Care. These evidence-based guidelines were designed to standardize and facilitate diabetes care in all regions of the Russian Federation.The ...
Alexander Yu. Mayorov +35 more
core +1 more source
Diabetes and obesity. The role of agonists glucagon-like peptide-1 of in the treatment of type 2 diabetes [PDF]
, 2018 Significant number of patients with type 2 diabetes mellitus are obese. It is known that even glucose intolerance, as well as diabetes, can lead to vascular complications.
Milena Е. Telnova, Nina A. Petunina
core +2 more sources
Nephroprotective potential of glucagon-like peptide-1 receptor agonists [PDF]
, 2020 Patients with diabetes mellitus (DM), which is a key factor in the development of kidney diseases, are increasingly competing for limited healthcare resources.
Igor A. Sklyanik +2 more
core +1 more source
An economic value of the glycated hemoglobin test in diabetes mellitus type 2 diagnosis [PDF]
, 2019 BACKGROUND: Diagnostic of diabetes mellitus type 2 (DM2T) in time is very actual for treatment and prevention of potential complications of illness. Fasting blood glucose test (FBG) is a widely used method of primary DM2T diagnose.
Aleksey A. Kurylev +7 more
core +1 more source
Diabetes mellitus type 2 in adults [PDF]
, 2020 Public organization “Russian Association of Endocrinologists”.
Alexander S. Ametov +34 more
core +2 more sources
Mechanisms of cardiovascular protection of non-insulin antidiabetic medications [PDF]
, 2018 Patients with type 2 diabetes mellitus die most frequently from cardiovascular disease (CVD). Metabolic control is a cornerstone of both primary and secondary prevention of CVD: its important is two-fold since the normalization of HbA1c not only ...
Avogaro, Angelo
core +2 more sources
Heart failure in diabetes: From an increased risk to a treatment target [PDF]
, 2018 Heart failure (HF) is one of the most common comorbidities of type 2 diabetes mellitus (T2DM) and poor glycaemic control can worsen the HF outcomes and increase the risk of hospitalisations.
Eberhard Standl
core +1 more source
The glucose-lowering therapy structure in special groups of type 2 diabetes mellitus patients based on data from the Moscow region register [PDF]
, 2019 BACKGROUND: Data of real clinical practice in diabetes mellitus (DM) register allow to evaluate features and trends in structure of glucose-lowering therapy (GLT).
Alexander V. Dreval +3 more
core +1 more source